Cargando…
Correction: Narongkiatikhun et al. Immunogenicity and Safety of Homologous and Heterologous Prime-Boost of CoronaVac(®) and ChAdOx1 nCoV-19 among Hemodialysis Patients: An Observational Prospective Cohort Study. Vaccines 2023, 11, 175
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611367/ https://www.ncbi.nlm.nih.gov/pubmed/37897029 http://dx.doi.org/10.3390/vaccines11101538 |
| _version_ | 1785128474668695552 |
|---|---|
| author | Narongkiatikhun, Phoom Noppakun, Kajohnsak Chaiwarith, Romanee Winichakoon, Poramed Vongsanim, Surachet Suteeka, Yuttitham Pongsuwan, Karn Kusirisin, Prit Wongsarikan, Nuttanun Fanhchaksai, Kanda Khamwan, Chantana Dankai, Dararat Ophascharoensuk, Vuddhidej |
| author_facet | Narongkiatikhun, Phoom Noppakun, Kajohnsak Chaiwarith, Romanee Winichakoon, Poramed Vongsanim, Surachet Suteeka, Yuttitham Pongsuwan, Karn Kusirisin, Prit Wongsarikan, Nuttanun Fanhchaksai, Kanda Khamwan, Chantana Dankai, Dararat Ophascharoensuk, Vuddhidej |
| author_sort | Narongkiatikhun, Phoom |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10611367 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | MDPI |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106113672023-10-28 Correction: Narongkiatikhun et al. Immunogenicity and Safety of Homologous and Heterologous Prime-Boost of CoronaVac(®) and ChAdOx1 nCoV-19 among Hemodialysis Patients: An Observational Prospective Cohort Study. Vaccines 2023, 11, 175 Narongkiatikhun, Phoom Noppakun, Kajohnsak Chaiwarith, Romanee Winichakoon, Poramed Vongsanim, Surachet Suteeka, Yuttitham Pongsuwan, Karn Kusirisin, Prit Wongsarikan, Nuttanun Fanhchaksai, Kanda Khamwan, Chantana Dankai, Dararat Ophascharoensuk, Vuddhidej Vaccines (Basel) Correction MDPI 2023-09-28 /pmc/articles/PMC10611367/ /pubmed/37897029 http://dx.doi.org/10.3390/vaccines11101538 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Correction Narongkiatikhun, Phoom Noppakun, Kajohnsak Chaiwarith, Romanee Winichakoon, Poramed Vongsanim, Surachet Suteeka, Yuttitham Pongsuwan, Karn Kusirisin, Prit Wongsarikan, Nuttanun Fanhchaksai, Kanda Khamwan, Chantana Dankai, Dararat Ophascharoensuk, Vuddhidej Correction: Narongkiatikhun et al. Immunogenicity and Safety of Homologous and Heterologous Prime-Boost of CoronaVac(®) and ChAdOx1 nCoV-19 among Hemodialysis Patients: An Observational Prospective Cohort Study. Vaccines 2023, 11, 175 |
| title | Correction: Narongkiatikhun et al. Immunogenicity and Safety of Homologous and Heterologous Prime-Boost of CoronaVac(®) and ChAdOx1 nCoV-19 among Hemodialysis Patients: An Observational Prospective Cohort Study. Vaccines 2023, 11, 175 |
| title_full | Correction: Narongkiatikhun et al. Immunogenicity and Safety of Homologous and Heterologous Prime-Boost of CoronaVac(®) and ChAdOx1 nCoV-19 among Hemodialysis Patients: An Observational Prospective Cohort Study. Vaccines 2023, 11, 175 |
| title_fullStr | Correction: Narongkiatikhun et al. Immunogenicity and Safety of Homologous and Heterologous Prime-Boost of CoronaVac(®) and ChAdOx1 nCoV-19 among Hemodialysis Patients: An Observational Prospective Cohort Study. Vaccines 2023, 11, 175 |
| title_full_unstemmed | Correction: Narongkiatikhun et al. Immunogenicity and Safety of Homologous and Heterologous Prime-Boost of CoronaVac(®) and ChAdOx1 nCoV-19 among Hemodialysis Patients: An Observational Prospective Cohort Study. Vaccines 2023, 11, 175 |
| title_short | Correction: Narongkiatikhun et al. Immunogenicity and Safety of Homologous and Heterologous Prime-Boost of CoronaVac(®) and ChAdOx1 nCoV-19 among Hemodialysis Patients: An Observational Prospective Cohort Study. Vaccines 2023, 11, 175 |
| title_sort | correction: narongkiatikhun et al. immunogenicity and safety of homologous and heterologous prime-boost of coronavac(®) and chadox1 ncov-19 among hemodialysis patients: an observational prospective cohort study. vaccines 2023, 11, 175 |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611367/ https://www.ncbi.nlm.nih.gov/pubmed/37897029 http://dx.doi.org/10.3390/vaccines11101538 |
| work_keys_str_mv | AT narongkiatikhunphoom correctionnarongkiatikhunetalimmunogenicityandsafetyofhomologousandheterologousprimeboostofcoronavacandchadox1ncov19amonghemodialysispatientsanobservationalprospectivecohortstudyvaccines202311175 AT noppakunkajohnsak correctionnarongkiatikhunetalimmunogenicityandsafetyofhomologousandheterologousprimeboostofcoronavacandchadox1ncov19amonghemodialysispatientsanobservationalprospectivecohortstudyvaccines202311175 AT chaiwarithromanee correctionnarongkiatikhunetalimmunogenicityandsafetyofhomologousandheterologousprimeboostofcoronavacandchadox1ncov19amonghemodialysispatientsanobservationalprospectivecohortstudyvaccines202311175 AT winichakoonporamed correctionnarongkiatikhunetalimmunogenicityandsafetyofhomologousandheterologousprimeboostofcoronavacandchadox1ncov19amonghemodialysispatientsanobservationalprospectivecohortstudyvaccines202311175 AT vongsanimsurachet correctionnarongkiatikhunetalimmunogenicityandsafetyofhomologousandheterologousprimeboostofcoronavacandchadox1ncov19amonghemodialysispatientsanobservationalprospectivecohortstudyvaccines202311175 AT suteekayuttitham correctionnarongkiatikhunetalimmunogenicityandsafetyofhomologousandheterologousprimeboostofcoronavacandchadox1ncov19amonghemodialysispatientsanobservationalprospectivecohortstudyvaccines202311175 AT pongsuwankarn correctionnarongkiatikhunetalimmunogenicityandsafetyofhomologousandheterologousprimeboostofcoronavacandchadox1ncov19amonghemodialysispatientsanobservationalprospectivecohortstudyvaccines202311175 AT kusirisinprit correctionnarongkiatikhunetalimmunogenicityandsafetyofhomologousandheterologousprimeboostofcoronavacandchadox1ncov19amonghemodialysispatientsanobservationalprospectivecohortstudyvaccines202311175 AT wongsarikannuttanun correctionnarongkiatikhunetalimmunogenicityandsafetyofhomologousandheterologousprimeboostofcoronavacandchadox1ncov19amonghemodialysispatientsanobservationalprospectivecohortstudyvaccines202311175 AT fanhchaksaikanda correctionnarongkiatikhunetalimmunogenicityandsafetyofhomologousandheterologousprimeboostofcoronavacandchadox1ncov19amonghemodialysispatientsanobservationalprospectivecohortstudyvaccines202311175 AT khamwanchantana correctionnarongkiatikhunetalimmunogenicityandsafetyofhomologousandheterologousprimeboostofcoronavacandchadox1ncov19amonghemodialysispatientsanobservationalprospectivecohortstudyvaccines202311175 AT dankaidararat correctionnarongkiatikhunetalimmunogenicityandsafetyofhomologousandheterologousprimeboostofcoronavacandchadox1ncov19amonghemodialysispatientsanobservationalprospectivecohortstudyvaccines202311175 AT ophascharoensukvuddhidej correctionnarongkiatikhunetalimmunogenicityandsafetyofhomologousandheterologousprimeboostofcoronavacandchadox1ncov19amonghemodialysispatientsanobservationalprospectivecohortstudyvaccines202311175 |